These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 37407931)

  • 1. The impact of COVID-19 on national program of colorectal cancer screening in Tehran, Iran: a multicenter study.
    Sadeghi A; Asadzadeh Aghdaei H; Khalafi MA; Nazemalhosseini-Mojarad E; Ketabi Moghadam P; Sohrabi MR
    BMC Cancer; 2023 Jul; 23(1):627. PubMed ID: 37407931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A delay in the diagnosis of colorectal cancer screened by fecal immunochemical tests during the COVID-19 pandemic: a longitudinal cohort study.
    Ishibashi F; Shida D; Suzuki S; Nagai M; Mochida K; Morishita T
    Int J Colorectal Dis; 2022 Dec; 37(12):2543-2546. PubMed ID: 36383225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the COVID-19 Pandemic on Fecal Immunochemical Testing, Colonoscopy Services, and Colorectal Neoplasia Detection in a Large United States Community-based Population.
    Lee JK; Lam AY; Jensen CD; Marks AR; Badalov J; Layefsky E; Kao K; Ho NJ; Schottinger JE; Ghai NR; Carlson CM; Halm EA; Green B; Li D; Corley DA; Levin TR
    Gastroenterology; 2022 Sep; 163(3):723-731.e6. PubMed ID: 35580655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
    Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
    BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening.
    Grobbee EJ; van der Vlugt M; van Vuuren AJ; Stroobants AK; Mallant-Hent RC; Lansdorp-Vogelaar I; Bossuyt PMM; Kuipers EJ; Dekker E; Spaander MCW
    Clin Gastroenterol Hepatol; 2020 Mar; 18(3):667-675.e1. PubMed ID: 31419575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the COVID-19 Pandemic on Colorectal Cancer Screening: a Systematic Review.
    Mazidimoradi A; Tiznobaik A; Salehiniya H
    J Gastrointest Cancer; 2022 Sep; 53(3):730-744. PubMed ID: 34406626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal Cancer Screening Pilot Project in Tehran-Iran, a Feasibility Study.
    Salimzadeh H; Sauvaget C; Delavari A; Sadeghi A; Amani M; Salimzadeh S; Karimi A; Ghanbari Motlagh A; Lucas E; Basu P; Malekzadeh R
    Arch Iran Med; 2023 Mar; 26(3):138-146. PubMed ID: 37543936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Évaluation de la gravité du cancer colorectal dépisté dans le contexte de la crise sanitaire liée au COVID19 en région Ile-de-France].
    Koïvogui A; Abihsera G; Le Trong T; Ait-Hadad H; Bernoux A; Delattre H; Vincelet C; Caroll R; Nicolet J
    Rev Epidemiol Sante Publique; 2023 Oct; 71(5):102124. PubMed ID: 37451076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the COVID-19 pandemic on colorectal cancer screening in New York City.
    Lee B; Young S; Williams R; Liang PS
    J Med Screen; 2023 Jun; 30(2):81-86. PubMed ID: 36164282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).
    Katičić M; Antoljak N; Kujundžić M; Stamenić V; Skoko Poljak D; Kramarić D; Stimac D; Strnad Pešikan M; Samija M; Ebling Z
    World J Gastroenterol; 2012 Aug; 18(32):4300-7. PubMed ID: 22969192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of delaying colonoscopies during the COVID-19 pandemic on colorectal cancer detection and prevention.
    Holland J; Cwintal M; Rigas G; Pang AJ; Vasilevsky CA; Morin N; Ghitulescu G; Faria J; Boutros M
    Surg Endosc; 2022 Dec; 36(12):9364-9373. PubMed ID: 35428894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term impact of the COVID-19 pandemic on a population-based screening program for colorectal cancer in Catalonia (Spain).
    Vives N; Binefa G; Vidal C; Milà N; Muñoz R; Guardiola V; Rial O; Garcia M
    Prev Med; 2022 Feb; 155():106929. PubMed ID: 34954239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal Cancer screening in ambulatory healthcare service clinics in Abu Dhabi, United Arab Emirates in 2015-2016.
    Almansoori A; Alzaabi M; Alketbi L
    BMC Cancer; 2021 Aug; 21(1):897. PubMed ID: 34362343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of Colon Cancer Screening by Fecal Immunochemical Test in Iran.
    Salimzadeh H; Bishehsari F; Sauvaget C; Amani M; Hamzehloo G; Nikfarjam A; Merat S; Delavari A; Malekzadeh R
    Arch Iran Med; 2017 Dec; 20(12):726-733. PubMed ID: 29664311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study.
    van Wifferen F; de Jonge L; Worthington J; Greuter MJE; Lew JB; Nadeau C; van den Puttelaar R; Feletto E; Yong JHE; Lansdorp-Vogelaar I; Canfell K; Coupé VMH;
    J Med Screen; 2022 Jun; 29(2):72-83. PubMed ID: 35100894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of COVID-19 pandemic in the colorectal cancer prevention.
    Del Vecchio Blanco G; Calabrese E; Biancone L; Monteleone G; Paoluzi OA
    Int J Colorectal Dis; 2020 Oct; 35(10):1951-1954. PubMed ID: 32500432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of COVID-19 pandemic on fecal immunochemical test screening uptake and compliance to diagnostic colonoscopy.
    Cheng SY; Chen CF; He HC; Chang LC; Hsu WF; Wu MS; Chiu HM
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1614-1619. PubMed ID: 33217055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The COVID-19 Pandemic: Identifying Adaptive Solutions for Colorectal Cancer Screening in Underserved Communities.
    Nodora JN; Gupta S; Howard N; Motadel K; Propst T; Rodriguez J; Schultz J; Velasquez S; Castañeda SF; Rabin B; Martínez ME
    J Natl Cancer Inst; 2021 Aug; 113(8):962-968. PubMed ID: 32780851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.